{
    "code": 0,
    "data": [
        {
            "sym": "SUDEEPPHRM",
            "disp": "Sudeep Pharma",
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Submission of Earnings Call Transcript for the earnings call held on 9th February 2026 to discuss the operational and financial performance of the Company for the third quarter and nine months ended on 31st December 2025.",
            "news_id": "2c173542-c044-4cb8-80a5-f4bcf80374b3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41aeb393-acbf-4a0a-a2e8-9b0587abebd2.pdf",
            "news_date": "2026-02-12 11:05:47",
            "seo": "sudeep-pharma-ltd",
            "ltp": 661.05,
            "ch": -1.3000000000000682,
            "pch": -0.19627085377822423,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 760039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Submission of Earnings Call Transcript for the earnings call held on 9th February 2026 to discuss the operational and financial performance of the Company for the third quarter and nine months ended on 31st December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41aeb393-acbf-4a0a-a2e8-9b0587abebd2.pdf",
            "news_date": "2026-02-12 11:05:47"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Submission of Audio Link for the call held on 9th February 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c79912f5-f633-4e7e-9569-68e1bed6c323.pdf",
            "news_date": "2026-02-09 14:12:37"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Submission of Audio Link for the Investors Call held on 9th February 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8567d169-f764-4027-a588-487ce0d304af.pdf",
            "news_date": "2026-02-09 14:03:54"
        },
        {
            "sym": "SUDEEPPHRM",
            "disp": "Sudeep Pharma",
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI (LODR) we hereby submit Investor Presentation for the unaudited financials as on third quarter and nine months ended on 31st December 2025",
            "news_id": "bba45379-6af4-4c47-b915-0e783a5604e6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ddd9338d-355f-4f2f-9c70-3d3d0095a3f5.pdf",
            "news_date": "2026-02-07 15:25:00",
            "seo": "sudeep-pharma-ltd",
            "ltp": 661.05,
            "ch": -1.3000000000000682,
            "pch": -0.19627085377822423,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 760039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI (LODR) we hereby submit Investor Presentation for the unaudited financials as on third quarter and nine months ended on 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ddd9338d-355f-4f2f-9c70-3d3d0095a3f5.pdf",
            "news_date": "2026-02-07 15:25:00"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation for Re-schedule of Earnings Call with Analysts/Investors on 09th February 2026 at 11:00 a.m.\r\n\r\nall the investors are requested to take note of the same.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c9c07df-03f8-444d-ab7b-653de92b591b.pdf",
            "news_date": "2026-02-07 14:19:02"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Pursuant to Regulation 30 and 47 of SEBI (LODR) please find attached newspaper publication for extract of un-audited financial results for the third quarter and nine months ended 31st December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c02942f4-4cf3-46a6-8a3c-ca239ccd49e3.pdf",
            "news_date": "2026-02-07 14:14:52"
        },
        {
            "sym": "SUDEEPPHRM",
            "disp": "Sudeep Pharma",
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results As On 31.12.2025",
            "news_body": "Submission of unaudited Financial results for the third quarter and nine months ended 31.12.2025",
            "news_id": "f051ff7f-3381-413d-997d-1be394fbf20f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43624ae0-8d39-4285-a1ba-7a2897b3e399.pdf",
            "news_date": "2026-02-06 18:08:23",
            "seo": "sudeep-pharma-ltd",
            "ltp": 661.05,
            "ch": -1.3000000000000682,
            "pch": -0.19627085377822423,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 760039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Un-Audited Financial Results As On 31.12.2025",
            "news_body": "Submission of unaudited Financial results for the third quarter and nine months ended 31.12.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43624ae0-8d39-4285-a1ba-7a2897b3e399.pdf",
            "news_date": "2026-02-06 18:08:23"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 06.02.2026",
            "news_body": "Submission of Unaudited Standalone & Consolidated Financials as on third quarter and nine months ended 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=271c4c55-a48a-4eb7-b4b7-1d84a0d21feb.pdf",
            "news_date": "2026-02-06 18:02:03"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Pursuant to the Regulation 30 of SEBI (LODR) Regulation 2015 we hereby submit that Mr. John Garcia (VP - Sales & Supply Chain) of Sudeep Pharma USA Inc designated as SMP vide his letter dated 04.02.2026 has tendered his resignation w.e.f. the close of Business hours on 06.02.2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53d896a6-6932-4e7a-a919-5746364f8d94.pdf",
            "news_date": "2026-02-05 10:04:31"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "This is to inform that the Earnings Call of the Company with Analysts/Investors to discuss the operational & financial performance for the quarter and nine ended on December 31 2025 is scheduled as below: \r\n\r\nDay & Date: Monday 09th February 2026\r\nTime: 11:30 a.m. IST \r\n\r\nRegistration Link and Access numbers: As per Annexure \r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e5ac45f-0e38-4a5c-a25e-f697d8a11125.pdf",
            "news_date": "2026-02-02 16:49:38"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Unaudited Financial Results As On 31St December 2025 Along With Other Business Items",
            "news_body": "Sudeep Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and Nine Months ended on 31st December 2025 along with other business items.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63597e68-7188-4151-b16f-eaaba909e1d0.pdf",
            "news_date": "2026-02-02 14:15:22"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR) - Intimation Of Approval For Purchase Of Rights In Leasehold Land In GIDC By Sudeep Advanced Materials Private Limited A Wholly Owned Subsidiary (WOS) Of The Company.",
            "news_body": "We hereby inform you that the Companys Wholly Owned Subsidiary i.e. Sudeep Advanced Materials Private Limited has purchased the rights in leasehold land in Dahej Gujarat (GIDC) from DCM Shriram Fine Chemicals Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7895c180-c3da-40bb-90bd-9c19d4e4892a.pdf",
            "news_date": "2026-01-22 17:13:20"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "General Update",
            "news_body": "Intimation for update in Corporate Identification Number (CIN) and status of the Company on the MCA portal.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2eb7f534-a501-46a8-bc75-43098a5566ea.pdf",
            "news_date": "2026-01-16 11:06:57"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Submission of Compliance Certificate Under Reg 74 (5) of SEBI (DP) Regulation 2018 for the Quarter ended 31st December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7bf4853a-d3f9-4ca7-b4db-6e59084ad5ae.pdf",
            "news_date": "2026-01-08 15:18:24"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Pursuant to the code of conduct on prevention of insider trading of Sudeep Pharma Limited and SEBI (PIT) Regulations 2015 the trading window for dealing in the securities of the company shall be closed for designated persons from Thursday 1st January 2026 and shall remain closed till 48 hours after the declaration of the un-audited financial results of the Company for the quarter ending on 31st December 2025 and other matters if any.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ae79b49-d16d-4984-88c7-65e598e47a9a.pdf",
            "news_date": "2025-12-26 14:32:21"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Submission of Audio Link for the Investors Call held on 22nd December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54e08e43-740f-41e6-a669-c37886ffbeaf.pdf",
            "news_date": "2025-12-22 16:25:54"
        },
        {
            "sym": "SUDEEPPHRM",
            "disp": "Sudeep Pharma",
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Submission of Investors Presentation",
            "news_id": "b2fa98ed-497f-425f-aa60-f9e54f3180f8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e62e087-62c8-4fa5-a09e-1f9b488bd0fd.pdf",
            "news_date": "2025-12-21 16:25:15",
            "seo": "sudeep-pharma-ltd",
            "ltp": 661.05,
            "ch": -1.3000000000000682,
            "pch": -0.19627085377822423,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 760039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Submission of Investors Presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e62e087-62c8-4fa5-a09e-1f9b488bd0fd.pdf",
            "news_date": "2025-12-21 16:25:15"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "we refer to our letter dated 19th December 2025 vide which we have submitted the Un-audited Financial Results (Standalone & Consolidated) of the Company for the second quarter and six months period ended 30th September 2025 we are now submitting herewith e-copies of the Extract of Un-audited Financial Results of the Company for the said period published in Business Standard English Language Newspaper and Vadodara Samachar Regional Language newspaper at Vadodara Gujarat on 20th December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee6c7572-4d0b-4d71-8d02-0dce258157a9.pdf",
            "news_date": "2025-12-20 10:18:52"
        },
        {
            "sym": "SUDEEPPHRM",
            "disp": "Sudeep Pharma",
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Financials As On Quarter And Half Year Ended 30Th September 2025",
            "news_body": "Submission of Financials as on 30.09.2025",
            "news_id": "5ed3f170-3351-49d8-aa04-4af7dd975f7c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e2a50b4-4553-414a-af0d-a16052de4276.pdf",
            "news_date": "2025-12-19 15:47:29",
            "seo": "sudeep-pharma-ltd",
            "ltp": 661.05,
            "ch": -1.3000000000000682,
            "pch": -0.19627085377822423,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 760039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Submission Of Financials As On Quarter And Half Year Ended 30Th September 2025",
            "news_body": "Submission of Financials as on 30.09.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e2a50b4-4553-414a-af0d-a16052de4276.pdf",
            "news_date": "2025-12-19 15:47:29"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 19Th December 2025",
            "news_body": "This is to inform you that the Board of Directors of the Company in their meeting held on Friday 19th December 2025 inter alia transacted the following business: \r\n  Considered and approved the Unaudited Standalone & Consolidated Financial Results for the quarter and half year ended on 30th September 2025. \r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5afab74-46ce-445d-aca2-6a1572033526.pdf",
            "news_date": "2025-12-19 15:43:47"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "This is to inform that the Earnings Call of the Company with Analysts/Investors to discuss the operational & financial performance for the quarter and half year ended on September 30 2025 is scheduled on Monday 22nd December 2025 at 11:30 A.M.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e6ed7573-faa4-4fef-9c36-5b188eb87a7f.pdf",
            "news_date": "2025-12-15 12:54:48"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Adoption Of Unaudited Financial Results For The Quarter And Half Year Ended On September 30 2025 And Other Business Items",
            "news_body": "Sudeep Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/12/2025 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended on September 30 2025 and other Business items",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75a64905-6d9d-4af1-9274-f446e5e10575.pdf",
            "news_date": "2025-12-15 12:21:16"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Unsecured Loan Granted To Sudeep Advanced Materials Private Limited A Wholly Owned Subsidiary (WOS) Of The Company",
            "news_body": "Pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations 2015 as amended we hereby inform you that the Company has granted an unsecured Loan to Sudeep Advanced Materials Private Limited a wholly owned subsidiary (\"WOS) of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=533aede9-19a2-4bda-869d-3dca52c092fc.pdf",
            "news_date": "2025-12-09 18:36:29"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation for Closure of Trading window w.e.f. 28th November 2025 till publication of Un-audited Financial Results for the quarter and half year ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18460835-77cc-48a7-99d1-8d5c0ed02a42.pdf",
            "news_date": "2025-11-28 13:41:41"
        },
        {
            "co_code": 70661,
            "bse_code": 544619,
            "isin": "INE0QPI01025",
            "ann_type": "General",
            "descriptor": "New Listing",
            "caption": "Listing of Equity Shares of Sudeep Pharma Ltd",
            "news_body": "Trading Members of the Exchange are hereby informed that effective from November 28 2025 the Equity Shares of Sudeep Pharma Ltd  (Scrip Code: 544619) are listed and admitted to dealings on the Exchange in the list of B Group Securities. For further details please refer to the notice no. 20251127- 58 dated November 27 2025.",
            "file_url": "",
            "news_date": "2025-11-28 08:01:29"
        }
    ]
}